Remove 2022 Remove Healthcare Remove Healthcare Provider Remove Pharma
article thumbnail

Value-based healthcare can help reduce costs

World of DTC Marketing

Why haven’t more employers addressed the rising costs of employee healthcare with value-based care? health insurers report billions as small providers face stress in the first quarter. This has to be upsetting to employers experiencing riding employee healthcare costs. The post Value-based healthcare can help reduce costs.

article thumbnail

The Imperative for KAM in Pharma

PM360

Over the past decade, macro trends in healthcare have pushed life sciences companies to pursue increasingly sophisticated key account management (KAM) strategies and capabilities to provide unique offerings and value. How should leading pharma companies respond? healthcare ecosystem. Understanding Trends.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Healthcare Watch October 2023

PM360

Doctor Docs: Targeting Trust Between Pharma and HCPs A new study shows the crucial link in pharma marketers’ digital engagement strategy with HCPs is in jeopardy—trust. and France regarding pharma-provided digital platforms. They’re not in the business of providing objective, non-biased data.

article thumbnail

Our predictions for Pharma in 2023

Impetus Digital

The growing role of artificial intelligence (AI) and the importance of the “human aspect” throughout Pharma operations. After more than two years of pandemic restrictions, many Pharma leaders are itching to meet with their key opinion leaders (KOLs) in person again, believing that’s what most KOLs want.

Pharma 99
article thumbnail

Deep Dive: Oncology 2022

pharmaphorum

As this issue’s contributors discuss, by working together pharma companies and healthcare providers can significantly enhance oncology treatment for patients. ASCO 2022: Checkpoint inhibitors, Enhertu in spotlight. The post Deep Dive: Oncology 2022 appeared first on. Read Deep Dive: Oncology in full.

article thumbnail

Improving Access to Medicine: The Role of Pharma Companies in Emerging Markets

PM360

In its 2022 edition, the Access to Medicine Foundation report 2 analyzed the access strategy of 180 products across the top 20 pharmaceutical companies, of which 102 are on the WHO essential medicine list. These partnerships can be with local governments, healthcare providers, local startups, and non-governmental organizations.

article thumbnail

The evolving role of social media in healthcare

pharmaphorum

In recent years, social media has evolved into an essential part of pharma operations, for better or worse. Below, I’m exploring a few ways that pharma teams are using social media and other online collaboration platforms to connect, educate, and influence. Healthcare Provider (HCP) marketing. Congress Coverage.

Media 87